Archived News

Apexian’s Mark Kelley Receives Innovation Award

Apex Therapeutics’ Dr. Mark Kelley received the 2015 Innovation to Enterprise award on November 4, 2015 at the IUPUI Innovation to Enterprise Forum & Showcase in Indianapolis. The event highlights the research and creative successes of our faculty, research scientists, and students from across the campus. The program featured an interactive look at the innovative & entrepreneurial projects arising from the research programs at IUPUI....

Broecker Notes Recent Company Milestones

Apex Therapeutics CEO, David Broecker, presented at the 2015 BIO International Convention in Philadelphia. June 16. He provided an update on the achievement of corporate milestones and outline the plans for the development of APX3330 for the treatment of pancreatic cancer. The company recently achieved several company milestones including: Issued patent US#9,040,505 on a method for inhibiting pancreatic cancer through the administration of APX3330.  This...

Mark Kelley speaks at Fort Wayne Riley Reception; talks about research

Nearly 5,000 times each year, a child from Northeast Indiana comes to Riley Hospital or one of its regional clinics for treatment. At the Riley Society reception in Fort Wayne last week, we were reminded how much our support means to those families, most of whom never expected to become “Riley families.” Apex Therapeutics and Riley cancer researcher and Huntington native Mark Kelley, Ph.D., explained...